Egypt’s hereditary-disease programme has screened 792,592 newborns

Egypt has screened 792,592 newborns for inherited conditions through its “100 Million Health” initiative, marking a large-scale expansion of early detection since the programme began on July 13, 2021. The Health and Population Ministry says the current first phase covers premature babies in neonatal units at ministry hospitals and looks for 19 genetic disorders. A later phase is intended to extend comprehensive screening to all newborns through health units nationwide.

Screening uses a small blood sample taken from a baby’s heel and analysed at Egyptian CDC laboratories. If an initial result indicates a condition, the child is referred promptly for confirmatory testing and free treatment under current clinical protocols.

The panel includes congenital hypothyroidism, phenylketonuria, cystic fibrosis, and several metabolic and enzyme disorders that may benefit from early action. To support families after screening, the ministry and the Supreme Council of University Hospitals have designated 56 specialist centres across Egypt. These provide treatment, regular follow-up, psychological support, and guidance for parents at no charge.